Moreover, it has been shown that specific genes (e.g. p16INK4A) are hypermethylated in multiple tumor types, which could lead to “false negatives” for HCC diagnosis due to the presence of another cancer. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.